Cargando…
P21 is not a prognostic marker for rectal cancer – five-year follow up study of rectal cancer in stages I–IV
The p21 participates in the regulation of DNA repair and replication, and modulation of apoptosis as well. After DNA damage, the p53-dependent induction of p21 results in cell cycle arrest or could trigger cell apoptosis. The objective of the study was the assessment of p21 immunoreactivity in recta...
Autores principales: | Kozłowska-Geller, Monika A., Głuszek, Stanisław Z., Lewitowicz, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836274/ https://www.ncbi.nlm.nih.gov/pubmed/33531872 http://dx.doi.org/10.5114/wo.2020.102632 |
Ejemplares similares
-
Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity
por: Kozłowska-Geller, Monika, et al.
Publicado: (2021) -
Could veterinarians be immune to contracting SARS-CoV-2?
por: Kozłowska-Geller, Monika Anna, et al.
Publicado: (2022) -
CD63 and GLUT-1 Overexpression Could Predict a Poor Clinical Outcome in GIST: A Study of 54 Cases with Follow-Up
por: Lewitowicz, Piotr, et al.
Publicado: (2016) -
Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer
por: Taha, Anas, et al.
Publicado: (2022) -
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
por: Benitez, Jose Carlos, et al.
Publicado: (2021)